UNLIMITED TURBO LONG - FRESENIUS Share Price

Certificat

DE000PF0D0C4

Market Closed - Boerse Frankfurt Warrants 01:20:13 04/05/2024 am IST
0.68 EUR -2.86% Intraday chart for UNLIMITED TURBO LONG - FRESENIUS
Current month+3.03%
1 month+94.29%
Date Price Change Volume
03/24/03 0.68 -2.86% 0
02/24/02 0.7 +6.06% 0
30/24/30 0.66 +3.13% 0
29/24/29 0.64 +4.92% 0
26/24/26 0.61 +1.67% 0

Real-time Boerse Frankfurt Warrants

Last update May 04, 2024 at 01:20 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF0D0C
ISINDE000PF0D0C4
Date issued 20/03/2020
Strike 21.21
Maturity Unlimited
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.83
Lowest since issue 0.025

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.95 EUR
Average target price
36.22 EUR
Spread / Average Target
+29.58%
Consensus